|
|
Office Locations:
|
2277 Research Blvd., Suite 225
Rockville, MD 20850
Phone: 202-539-1222
| | |
|
|
|
|
|
Life Sciences & Healthcare
|
|
|
|
Hibiscus Capital Management is dedicated to providing the people, capital, and technology necessary to advance novel therapeutic and diagnostic approaches for patients who currently have no therapeutic options. The private investment firm was co-founded by Josh Barer, who operates Barer & Son Capital with his father Sol Barer, one of the founders of Celgene Corp. 25% of fund assets are dedicated to participating in passive investments where Hibiscus does not lead, or supporting existing investments and companies that have previously been identified. Technologies, products, and business models are typically selected and designed to reach proof of concept or a meaningful clinical inflection within 1-3 years, representing significant potential value creation.
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
